Lovastatin attenuates glyoxal-induced toxicity on rat liver mitochondria. (December 2021)

• Record Type: Journal Article
• Authors: Hosseinzadeh, A; Mehrzadi, S; Rezaei, M; Badavi, M; Nesari, A; Goudarzi, M
• Is Part Of: Human & experimental toxicology. Volume 40:Number 12(2021)
• Page Start: 2215
• Page End: 2222
• Publication Date: 2021-12
• Subjects: Lovastatin -- glyoxal -- oxidative stress -- mitochondria; Toxicology -- Periodicals; 615.9
• DOI: 10.1177/09603271211027939
• Languages: English
• ISSNs: 0960-3271

Abstract

Alpha-dicarbonyls such as glyoxal (GO) trigger mitochondrial dysfunction resulting in the development of different diabetic complications. The present study investigated the effects of lovastatin against GO-induced toxicity on rat liver mitochondria. The rat liver mitochondria (0.5 mg protein/mL) were treated with various concentrations of lovastatin (1, 5, 10 µM) at 37°C for 30 min and then exposed to GO (3 mM) at 37°C for 30 min. Oxidative stress markers including MDA, reactive oxygen species (ROS), glutathione (GSH) and protein carbonylation (PC) level were measured. Mitochondrial complex II activity and mitochondrial membrane potential (MMP) were assessed for evaluating mitochondrial function. Glyoxal significantly increased the level of ROS, PC and MDA. This effect was associated with the reduction of MMP, complex II activity and GSH content. Pre-treatment with lovastatin potentially reversed GO-induced mitochondrial toxicity. These results suggest that lovastatin have a protective effect against GO-induced toxicity in isolated rat liver mitochondria.